DocDollars

Bard Peripheral Vascular, Inc.

AZ · United States · Reporting entity ID 100000005481

Total reported 2019–2025
$47.2M
#183 of 2,960 reporting companies — 0.1% of all reported industry payments
$36.5M in general payments across 69,648 records, plus $10.7M in research funding across 977 records.

How it breaks down

General payments $36,513,930
Research funding $10,734,386

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Bard Peripheral Vascular, Inc. reported $47.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #183 of 2,960 reporting companies. 23% of that was research funding and 77% general payments such as consulting, speaking, food and travel. 69,648 general payment records and 977 research records were filed.

Common questions about Bard Peripheral Vascular, Inc.

How much has Bard Peripheral Vascular, Inc. paid US doctors?

Bard Peripheral Vascular, Inc. reported $47,248,316 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $36,513,930 in general payments, $10,734,386 in research funding.

How does Bard Peripheral Vascular, Inc. rank among drug and device companies?

It ranks #183 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Bard Peripheral Vascular, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.